Engineered bacteria assist CAR-cell immunotherapy.
10.1016/j.apsb.2025.01.020
- Author:
Tianyu SHAO
1
;
Manman XU
1
;
Jie LI
1
;
Xiao ZHAO
2
Author Information
1. Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
2. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
- Publication Type:Letter
- Keywords:
Antigen recognition;
Cancer immunotherapy;
Challenge;
Chimeric antigen receptor immunotherapy;
Cytotoxicity effects;
Engineered bacteria;
Solid tumor;
Tumor microenvironment
- From:
Acta Pharmaceutica Sinica B
2025;15(3):1703-1705
- CountryChina
- Language:English
